BiocSol raised €4.4M in a funding round in Feb 2025. The company is based in Louvain-la-Neuve, Belgium. Investors in the round: Pymwymic, Win4company. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €4.4M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
